Mitragynine pseudoindoxyl (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mitragynine pseudoindoxyl" in English language version.

refsWebsite

Global rank English rank

18nih.gov

4^th place

12doi.org

2^nd place

1semanticscholar.org

11^th place

8^th place

1chemrxiv.org

low place

chemrxiv.org

Angyal P, Hegedüs K, Mészáros BB, Daru J, Dudás Á, Galambos AR, et al. (2023-02-02). "Syntheses and structural plasticity of kratom pseudoindoxyl metabolites". ChemRxiv. doi:10.26434/chemrxiv-2023-62vzz-v2.

doi.org

Jansen KL, Prast CJ (1988). "Ethnopharmacology of kratom and the Mitragyna alkaloids". Journal of Ethnopharmacology. 23 (1): 115–119. doi:10.1016/0378-8741(88)90121-3. PMID 3419199.
Kamble SH, León F, King TI, Berthold EC, Lopera-Londoño C, Siva Rama Raju K, et al. (December 2020). "Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy". ACS Pharmacology & Translational Science. 3 (6): 1063–1068. doi:10.1021/acsptsci.0c00075. PMC 7737207. PMID 33344889.
Váradi A, Marrone GF, Palmer TC, Narayan A, Szabó MR, Le Rouzic V, et al. (September 2016). "Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2". Journal of Medicinal Chemistry. 59 (18): 8381–8397. doi:10.1021/acs.jmedchem.6b00748. PMC 5344672. PMID 27556704.
Qu Q, Huang W, Aydin D, Paggi JM, Seven AB, Wang H, et al. (April 2023). "Insights into distinct signaling profiles of the µOR activated by diverse agonists". Nature Chemical Biology. 19 (4): 423–430. doi:10.1038/s41589-022-01208-y. PMC 11098091. PMID 36411392. S2CID 245021836.
Spetea M, Schmidhammer H (June 2019). "Unveiling 7-Hydroxymitragynine as the Key Active Metabolite of Mitragynine and the Promise for Creating Novel Pain Relievers". ACS Central Science. 5 (6): 936–938. doi:10.1021/acscentsci.9b00462. PMC 6598155. PMID 31263752.
Kamble SH, León F, King TI, Berthold EC, Lopera-Londoño C, Siva Rama Raju K, et al. (December 2020). "Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy". ACS Pharmacology & Translational Science. 3 (6): 1063–1068. doi:10.1021/acsptsci.0c00075. PMC 7737207. PMID 33344889.
Chakraborty S, Uprety R, Slocum ST, Irie T, Le Rouzic V, Li X, et al. (November 2021). "Oxidative Metabolism as a Modulator of Kratom's Biological Actions". Journal of Medicinal Chemistry. 64 (22): 16553–16572. doi:10.1021/acs.jmedchem.1c01111. PMC 8673317. PMID 34783240.
Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, Ponglux D, et al. (April 2002). "Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands". Journal of Medicinal Chemistry. 45 (9): 1949–1956. doi:10.1021/jm010576e. PMID 11960505.
Yamamoto LT, Horie S, Takayama H, Aimi N, Sakai S, Yano S, et al. (July 1999). "Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa". General Pharmacology. 33 (1): 73–81. doi:10.1016/S0306-3623(98)00265-1. PMID 10428019.
Kim J, Schneekloth JS, Sorensen EJ (September 2012). "A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reaction". Chemical Science. 3 (9): 2849–2852. doi:10.1039/C2SC20669B. PMC 3714104. PMID 23878716.
Angyal P, Hegedüs K, Mészáros BB, Daru J, Dudás Á, Galambos AR, et al. (2023-02-02). "Syntheses and structural plasticity of kratom pseudoindoxyl metabolites". ChemRxiv. doi:10.26434/chemrxiv-2023-62vzz-v2.
Angyal P, Hegedüs K, Mészáros BB, Daru J, Dudás Á, Galambos AR, et al. (June 2023). "Total Synthesis and Structural Plasticity of Kratom Pseudoindoxyl Metabolites". Angewandte Chemie. 62 (35): e202303700. doi:10.1002/anie.202303700. PMID 37332089.

nih.gov

pubmed.ncbi.nlm.nih.gov

Jansen KL, Prast CJ (1988). "Ethnopharmacology of kratom and the Mitragyna alkaloids". Journal of Ethnopharmacology. 23 (1): 115–119. doi:10.1016/0378-8741(88)90121-3. PMID 3419199.
Kamble SH, León F, King TI, Berthold EC, Lopera-Londoño C, Siva Rama Raju K, et al. (December 2020). "Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy". ACS Pharmacology & Translational Science. 3 (6): 1063–1068. doi:10.1021/acsptsci.0c00075. PMC 7737207. PMID 33344889.
Váradi A, Marrone GF, Palmer TC, Narayan A, Szabó MR, Le Rouzic V, et al. (September 2016). "Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2". Journal of Medicinal Chemistry. 59 (18): 8381–8397. doi:10.1021/acs.jmedchem.6b00748. PMC 5344672. PMID 27556704.
Qu Q, Huang W, Aydin D, Paggi JM, Seven AB, Wang H, et al. (April 2023). "Insights into distinct signaling profiles of the µOR activated by diverse agonists". Nature Chemical Biology. 19 (4): 423–430. doi:10.1038/s41589-022-01208-y. PMC 11098091. PMID 36411392. S2CID 245021836.
Spetea M, Schmidhammer H (June 2019). "Unveiling 7-Hydroxymitragynine as the Key Active Metabolite of Mitragynine and the Promise for Creating Novel Pain Relievers". ACS Central Science. 5 (6): 936–938. doi:10.1021/acscentsci.9b00462. PMC 6598155. PMID 31263752.
Kamble SH, León F, King TI, Berthold EC, Lopera-Londoño C, Siva Rama Raju K, et al. (December 2020). "Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy". ACS Pharmacology & Translational Science. 3 (6): 1063–1068. doi:10.1021/acsptsci.0c00075. PMC 7737207. PMID 33344889.
Chakraborty S, Uprety R, Slocum ST, Irie T, Le Rouzic V, Li X, et al. (November 2021). "Oxidative Metabolism as a Modulator of Kratom's Biological Actions". Journal of Medicinal Chemistry. 64 (22): 16553–16572. doi:10.1021/acs.jmedchem.1c01111. PMC 8673317. PMID 34783240.
Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, Ponglux D, et al. (April 2002). "Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands". Journal of Medicinal Chemistry. 45 (9): 1949–1956. doi:10.1021/jm010576e. PMID 11960505.
Yamamoto LT, Horie S, Takayama H, Aimi N, Sakai S, Yano S, et al. (July 1999). "Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa". General Pharmacology. 33 (1): 73–81. doi:10.1016/S0306-3623(98)00265-1. PMID 10428019.
Kim J, Schneekloth JS, Sorensen EJ (September 2012). "A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reaction". Chemical Science. 3 (9): 2849–2852. doi:10.1039/C2SC20669B. PMC 3714104. PMID 23878716.
Angyal P, Hegedüs K, Mészáros BB, Daru J, Dudás Á, Galambos AR, et al. (June 2023). "Total Synthesis and Structural Plasticity of Kratom Pseudoindoxyl Metabolites". Angewandte Chemie. 62 (35): e202303700. doi:10.1002/anie.202303700. PMID 37332089.

ncbi.nlm.nih.gov

Kamble SH, León F, King TI, Berthold EC, Lopera-Londoño C, Siva Rama Raju K, et al. (December 2020). "Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy". ACS Pharmacology & Translational Science. 3 (6): 1063–1068. doi:10.1021/acsptsci.0c00075. PMC 7737207. PMID 33344889.
Váradi A, Marrone GF, Palmer TC, Narayan A, Szabó MR, Le Rouzic V, et al. (September 2016). "Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2". Journal of Medicinal Chemistry. 59 (18): 8381–8397. doi:10.1021/acs.jmedchem.6b00748. PMC 5344672. PMID 27556704.
Qu Q, Huang W, Aydin D, Paggi JM, Seven AB, Wang H, et al. (April 2023). "Insights into distinct signaling profiles of the µOR activated by diverse agonists". Nature Chemical Biology. 19 (4): 423–430. doi:10.1038/s41589-022-01208-y. PMC 11098091. PMID 36411392. S2CID 245021836.
Spetea M, Schmidhammer H (June 2019). "Unveiling 7-Hydroxymitragynine as the Key Active Metabolite of Mitragynine and the Promise for Creating Novel Pain Relievers". ACS Central Science. 5 (6): 936–938. doi:10.1021/acscentsci.9b00462. PMC 6598155. PMID 31263752.
Kamble SH, León F, King TI, Berthold EC, Lopera-Londoño C, Siva Rama Raju K, et al. (December 2020). "Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy". ACS Pharmacology & Translational Science. 3 (6): 1063–1068. doi:10.1021/acsptsci.0c00075. PMC 7737207. PMID 33344889.
Chakraborty S, Uprety R, Slocum ST, Irie T, Le Rouzic V, Li X, et al. (November 2021). "Oxidative Metabolism as a Modulator of Kratom's Biological Actions". Journal of Medicinal Chemistry. 64 (22): 16553–16572. doi:10.1021/acs.jmedchem.1c01111. PMC 8673317. PMID 34783240.
Kim J, Schneekloth JS, Sorensen EJ (September 2012). "A chemical synthesis of 11-methoxy mitragynine pseudoindoxyl featuring the interrupted Ugi reaction". Chemical Science. 3 (9): 2849–2852. doi:10.1039/C2SC20669B. PMC 3714104. PMID 23878716.

semanticscholar.org

api.semanticscholar.org

Qu Q, Huang W, Aydin D, Paggi JM, Seven AB, Wang H, et al. (April 2023). "Insights into distinct signaling profiles of the µOR activated by diverse agonists". Nature Chemical Biology. 19 (4): 423–430. doi:10.1038/s41589-022-01208-y. PMC 11098091. PMID 36411392. S2CID 245021836.